Trade LGVN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Longeveron Inc. Class A (LGVN) is trading at US$6.81, up 3.50% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$26.94M. Over the past 52 weeks, LGVN has traded between US$4.75 and US$12.30. On Syfe you can trade LGVN with $0 commission and add it to your watchlist.
| Previous close | US$6.58 |
|---|---|
| Market cap | US$26.94M |
| 52-week range | US$4.75 – US$12.30 |
| Volume | 40.1K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Longeveron Inc. Class A
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Year: 2021
Longeveron Names Marie Washburn as CFO
Jul 6, 8:24 PM · MT Newswires
Longeveron Granted SME Status by European Medicines Agency
Jun 9, 1:52 PM · MT Newswires
Longeveron Files Prospectus for Sale of Up to 30.9 Million Shares by Stockholders
Apr 10, 8:41 PM · MT Newswires
Longeveron Inc. Class A (LGVN) stock is trading at US$6.81, +3.50% from the previous close of US$6.58.
The market cap for Longeveron Inc. Class A (LGVN) stock is approximately US$26.94M.
The 52-week high for Longeveron Inc. Class A (LGVN) stock is US$12.30.
The 52-week low for Longeveron Inc. Class A (LGVN) stock is US$4.75.
Longeveron Inc. Class A (LGVN) does not currently pay a dividend.
Stay on top of LGVN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
